(11 March 2021) Groundbreaking research recently published by Liang Group scientists in eLife indicated a better cholesterol profile for those who maintain healthy lifestyle habits in concert with cholesterol-lowering medications. This study, led by postdoctoral research fellow Jiahui Si, found that while both methods to lowering LDL cholesterol are effective, cholesterol-lowering medications are less so … Continue reading “Healthy lifestyle habits, cholesterol-lowering medications, and improved cholesterol profile”
Metabolomics
A ‘metabolic signature’ could measure adherence to Mediterranean Diet & could predict risk of CVD
(14 May 2020) Research recently published in the European Heart Journal identified a ‘metabolic signature’ consisted of 67 metabolites that can measure adherence and metabolic response to the Mediterranean Diet and may help predict future risk of cardiovascular disease. Read more about the paper in the recent HSPH press release.
Metabolomics: Using mass spectrometry to detect metabolite features
(2019) Mass spectrometry (MS) is an analytical chemistry technique that can detect thousands of metabolite features, it is important to separate potential measurement artifacts before downstream analyses (Chaffin and Cao et al 2019 Journal of Proteome Research)
Metabolomics: Type-2 diabetes risk assessment
(September 2016) Combining metabolites with traditional risk factors can greatly improve risk assessment for type-2 diabetes in Chinese samples (Sun, Liang et al 2016 Diabetes Care).
